Drugs / Recombinant Human Somatropin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03800810 | May 2015 → May 2019 | osteoarthritis, knee | Indonesia University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Human Somatropin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03800810 ↗ |
| Known as | Novell-Eutropin | “8 IU recombinant human somatropin (Novell-Eutropin®, Novell Pharmaceutical Laboratories)” NCT03800810 ↗ |
| Modality | Protein / enzyme biologic | “8 IU recombinant human somatropin” NCT03800810 ↗ |
| Route | Other | “Intraarticular injection” NCT03800810 ↗ |